TERIFRAC 750MCG INJECTION

Terifrac 750mcg injection has the active ingredient, Teriparatide. Terifrac 750mcg injection is an artificial version of the hormone parathyroid (PTH) created by the parathyroid glands and is utilized to treat osteoporosis. Osteoporosis is a disease characterized by weak bones, increasing the chance of fractures. Osteoporosis-related fractures can significantly affect a person’s overall health as they cause pain and limit mobility. Terifrac 750mcg injections function in promoting the development of new bone tissue as well as increasing bone mineral density. The drug has been demonstrated to accelerate the healing process of bone for patients suffering from fractures. It helps to create a callus, the bridge of bone that is formed as healing proceeds, which leads to faster and more effective healing.
Patients who have a history of allergy or hypersensitivity to Terifrac 750mcg injection or one of the components should not take this drug. It is not recommended for those who have any previous history of skeletal malignancies like osteosarcoma or who have bone metastases. If a patient has had prior radiation therapy that affected the skeleton, then the treatment is not recommended due to the risk of developing osteosarcoma.